Kristin Bergethon

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata et al. · Science Translational Medicine · 2011 · 3.5K citations · Full text

<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers

Kristin Bergethon, Alice T. Shaw, Sai‐Hong Ignatius Ou et al. · Journal of Clinical Oncology · 2012 · 1.5K citations · Full text

Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification

Sai‐Hong Ignatius Ou, Eunice L. Kwak, Christina T. Siwak-Tapp et al. · Journal of Thoracic Oncology · 2011 · 433 citations

Tumor Biology, Oncology, Medicine +11

<i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib

Jochen K. Lennerz, Eunice L. Kwak, A. B. Ackerman et al. · Journal of Clinical Oncology · 2011 · 419 citations · Full text

<i>BRAF</i> Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation

Ryan B. Corcoran, Dora Dias‐Santagata, Kristin Bergethon et al. · Science Signaling · 2010 · 352 citations